• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯甲噻唑对正常和肝纤维化大鼠二乙基亚硝胺毒代动力学的抑制作用。

Inhibitory effect of chlormethiazole on the toxicokinetics of diethylnitrosamine in normal and hepatofibrotic rats.

机构信息

Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou, Henan, China.

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

出版信息

Drug Chem Toxicol. 2019 Nov;42(6):600-607. doi: 10.1080/01480545.2018.1455204. Epub 2018 Apr 12.

DOI:10.1080/01480545.2018.1455204
PMID:29648470
Abstract

The effect of chlormethiazole (CMZ) at single and multiple doses on the toxicokinetics of diethylnitrosamine (DEN) was investigated in normal rats and those with DEN-induced liver fibrosis. Twelve rats were treated with DEN (50 mg/kg) alone and in combination with a single dose of CMZ (10, 50, or 100 mg/kg) by intraperitoneal (i.p.) injection. In a multiple dose test, six rats were treated with CMZ (50 mg/kg) for 7 d with addition of DEN (50 mg/kg) on days 1 and 7. Lastly, 12 rats were treated with DEN (50 mg/kg) by i.p. injection twice a week for 4 consecutive weeks, followed by weekly injections for another 8 weeks to build the model of liver fibrosis. Following this induction, the 12 rats were given CMZ (50 mg/kg) combined with DEN (50 mg/kg) to study the inhibitory effect of CMZ on DEN metabolism in hepatofibrotic rats. Serial blood samples were also collected and analyzed by a validated high-performance liquid chromatography (HPLC) method. A single-dose CMZ treatment decreased DEN clearance (CL), prolonged the , and increased the 'area under the curve' (AUC) for DEN in normal and hepatofibrotic rats relative to rats that did not receive CMZ. Treatment with CMZ for 7 d further prolonged the for DEN but did not alter the CL and AUC relative to a single CMZ treatment. These results suggest that CMZ significantly inhibits the metabolism of DEN in normal and hepatofibrotic rats.

摘要

氯氮卓(CMZ)单次和多次给药对二乙基亚硝胺(DEN)毒代动力学的影响在正常大鼠和 DEN 诱导的肝纤维化大鼠中进行了研究。12 只大鼠单独用 DEN(50mg/kg)处理,并用腹腔注射(i.p.)CMZ(10、50 或 100mg/kg)单次剂量处理。在多次剂量试验中,6 只大鼠用 CMZ(50mg/kg)治疗 7d,在第 1 天和第 7 天加入 DEN(50mg/kg)。最后,12 只大鼠用 DEN(50mg/kg)通过 i.p.注射每周两次连续 4 周,然后每周注射一次,共 8 周,建立肝纤维化模型。诱导后,这 12 只大鼠给予 CMZ(50mg/kg)联合 DEN(50mg/kg),研究 CMZ 对肝纤维化大鼠 DEN 代谢的抑制作用。还收集并通过验证的高效液相色谱(HPLC)方法分析了连续的血样。单次 CMZ 处理降低了 DEN 清除率(CL),延长了 ,并增加了 DEN 在正常和肝纤维化大鼠中的“曲线下面积”(AUC),而未接受 CMZ 处理的大鼠则没有。用 CMZ 治疗 7d 进一步延长了 DEN 的 ,但与单次 CMZ 治疗相比,CL 和 AUC 没有改变。这些结果表明,CMZ 显著抑制了正常和肝纤维化大鼠 DEN 的代谢。

相似文献

1
Inhibitory effect of chlormethiazole on the toxicokinetics of diethylnitrosamine in normal and hepatofibrotic rats.氯甲噻唑对正常和肝纤维化大鼠二乙基亚硝胺毒代动力学的抑制作用。
Drug Chem Toxicol. 2019 Nov;42(6):600-607. doi: 10.1080/01480545.2018.1455204. Epub 2018 Apr 12.
2
Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.二乙基亚硝胺诱导的大鼠肝细胞癌中的肝脏炎症-纤维化-癌症轴
J Cancer Res Clin Oncol. 2017 May;143(5):821-834. doi: 10.1007/s00432-017-2364-z. Epub 2017 Feb 25.
3
Post-translational inhibition of cytochrome P-450 2E1 expression by chlomethiazole in Fao hepatoma cells.氯美噻唑对Fao肝癌细胞中细胞色素P-450 2E1表达的翻译后抑制作用。
J Pharmacol Exp Ther. 1999 May;289(2):847-52.
4
Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver.氯美噻唑对细胞色素P4502E1的抑制作用减轻了急性乙醇诱导的脂肪肝。
Chem Biol Interact. 2014 Oct 5;222:18-26. doi: 10.1016/j.cbi.2014.08.009. Epub 2014 Aug 24.
5
Cytochrome P450 2E1 inhibition prevents hepatic carcinogenesis induced by diethylnitrosamine in alcohol-fed rats.细胞色素P450 2E1抑制可预防酒精喂养大鼠中由二乙基亚硝胺诱导的肝癌发生。
Hepatobiliary Surg Nutr. 2012 Dec;1(1):5-18. doi: 10.3978/j.issn.2304-3881.2012.11.05. Epub 2012 Nov 30.
6
Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.2-[¹⁸F]-氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描在肝硬化肝细胞癌大鼠模型中的评估
Biomed Mater Eng. 2015;26 Suppl 1:S1669-76. doi: 10.3233/BME-151466.
7
Protective Effects of Ethyl Acetate Soluble Fraction of Limonium tetragonum on Diethylnitrosamine-Induced Liver Fibrosis in Rats.盐角草乙酸乙酯可溶部位对二乙基亚硝胺诱导的大鼠肝纤维化的保护作用
Biol Pharm Bull. 2016;39(6):1022-8. doi: 10.1248/bpb.b15-01047.
8
Pro-Resolving Lipid Mediator Resolvin E1 Mitigates the Progress of Diethylnitrosamine-Induced Liver Fibrosis in Sprague-Dawley Rats by Attenuating Fibrogenesis and Restricting Proliferation.促消退脂质介质(resolvin) E1 通过减弱纤维化和限制增殖减轻二乙基亚硝胺诱导的 Sprague-Dawley 大鼠肝纤维化的进展。
Int J Mol Sci. 2020 Nov 22;21(22):8827. doi: 10.3390/ijms21228827.
9
Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver.氯美噻唑作为大鼠肝脏中细胞色素P450 2E1表达的有效抑制剂。
J Pharmacol Exp Ther. 1994 Jun;269(3):1286-91.
10
Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.吲哚 - 3 - 甲醇对二乙基亚硝胺诱导的斯普拉格 - 道利大鼠肝脏中癌前谷胱甘肽S - 转移酶胎盘型阳性肝细胞灶的双相修饰作用。
Jpn J Cancer Res. 1994 Jun;85(6):578-83. doi: 10.1111/j.1349-7006.1994.tb02399.x.

引用本文的文献

1
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization.CYP2E1抑制剂Q11通过抑制M2巨噬细胞极化发挥抗肝细胞癌作用。
Cancer Immunol Immunother. 2024 Dec 30;74(1):35. doi: 10.1007/s00262-024-03912-1.
2
Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti-Tumor Agent.鉴定细胞色素 P450 2E1 为胶质瘤的新靶标及开发其抑制剂作为抗肿瘤药物。
Adv Sci (Weinh). 2023 Aug;10(23):e2301096. doi: 10.1002/advs.202301096. Epub 2023 Jun 7.
3
The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.
POR 基因 rs10954732 多态性降低肝细胞癌易感性,hepsin 作为基于蛋白质组学的预后生物标志物与免疫浸润相关。
J Transl Med. 2022 Feb 14;20(1):88. doi: 10.1186/s12967-022-03282-1.